AstraZeneca COVID-19 Vaccine Suspended In Some European Countries Due To Blood Clot Concerns; Still On Trial In Chicago

Credit: CBS 2 Chicago

Duration: 02:04s 15 Mar 2021 0 shares 1 views

AstraZeneca COVID-19 Vaccine Suspended In Some European Countries Due To Blood Clot Concerns; Still On Trial In Chicago

There is growing concern that the AstraZeneca vaccine, which is being tested in Chicago, might be linked to blood clots.

You might like

Related news coverage

Daily Covid-19 Minute: Astrazeneca Vaccine

Daily Covid-19 Minute: Astrazeneca Vaccine

CBS 62 Detroit 25 Mar 2021

Drugmaker AstraZeneca announced some promising results from their phase 3 covid vaccine trial reporting their vaccine was 79%..

Boris Johnson Receives AstraZeneca Vaccine

Boris Johnson Receives AstraZeneca Vaccine

ODN

19 Mar 2021

Major European nations suspend use of AstraZeneca vaccine due to blood clot concerns

Major European nations suspend use of AstraZeneca vaccine due to blood clot concerns

WXYZ Detroit

15 Mar 2021

Advertisement